REG - BkofA Merrill LynchMedtronic, Inc.Covidien plc - ISE Only - (38.5) <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 15:18

RNS Number : 0103Q
Bank of America Merrill Lynch
26 August 2014
FORM38.5(b)
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE38.5(b)OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DEALINGSBYCONNECTEDEXEMPTPRINCIPALTRADERSWITHOUTRECOGNISEDINTERMEDIARYSTATUS,ORWITHRECOGNISEDINTERMEDIARYSTATUSBUTNOTDEALINGINACLIENT-SERVINGCAPACITY
1.
KEY INFORMATION
Nameofexemptprincipaltrader
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
Companydealtin
Medtronic Inc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note1)
Common - US5850551061
Dateofdealing
25/08/2014
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

Long
Short
Number
%
Number
%
(1) 
Relevant securities 
344,679
0.035% 
156,701
0.016% 
(2) 
Derivatives (other than options) 
0
0% 
0
0% 
(3) 
Options and agreements to purchase/sell 
607,400
0.061% 
426,400
0.043% 
Total
952,079
0.096% 
583,101
0.059% 
(b)
Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 
Class of relevant security: 


Long
Short
Number
%
Number
%
(1) 
Relevant securities 




(2) 
Derivatives (other than options) 




(3) 
Options and agreements to purchase/sell 




Total




3.
DEALINGS (Note 3)
(a)
Purchases and Sales 
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
(USD) 
Purchase
261
63.59
Purchase
1775
63.6
Purchase
9589
63.61
Purchase
100
63.615
Purchase
5098
63.62
Purchase
3458
63.63
Purchase
601
63.635
Purchase
14282
63.64
Purchase
296
63.645
Purchase
3980
63.65
Purchase
5494
63.66
Purchase
7839
63.67
Purchase
100
63.675
Purchase
13341
63.68
Purchase
591
63.685
Purchase
30146
63.69
Purchase
505
63.695
Purchase
5147
63.7
Purchase
54073
63.71
Purchase
100
63.715
Purchase
5690
63.72
Purchase
4328
63.73
Purchase
878
63.89
Sale
261
63.59
Sale
520
63.6
Sale
98
63.63
Sale
29
63.64
Sale
2200
63.68
Sale
100
63.685
Sale
400
63.69
Sale
144880
63.71
Sale
777
63.86
Sale
83
63.87
Sale
2233
63.89
Sale
4348
63.9
Sale
1538
63.91
Sale
200
63.915
Sale
2820
63.92
Sale
975
63.93
Sale
2844
63.94
Sale
512
63.95
Sale
100
63.96
Sale
1852
63.97
Sale
100
63.98
Sale
302
64
Sale
15
64.03
Sale
303
64.05
Sale
182
64.06
(b)
Derivatives transactions (other than options transactions) 
Product name,
e.g. CFD 
Nature of transaction
(Note 5)
Number of relevant securities
(Note 6)
Price per unit
(Note 4)
N/A
N/A
N/A
N/A
(c)
Options transactions in respect of existing relevant securities 
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call option 
Number of securities
Exercise price per
unit (Note 4)
N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)
Details
Price per unit
(if applicable) (Note 4)
N/A
N/A
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person 
disclosing and any other person relating to the voting rights of any relevant 
securities under any option referred to on this form or relating to the voting rights 
or future acquisition or disposal of any relevant securities to which any derivative 
referred to on this form is referenced. If none, this should be stated. 
Borrow of 122,800 shares
1 shares returned
24 shares returned
Is a Supplemental Form 38.5(b) attached? (Note 8)
No
Date of disclosure:
26/08/2014
Contact name:
Stacy Otieno
Telephone number:
0207 995 1335
Name of offeree/offerer with which connected 
Medtronic Inc
Nature of connection (Note 9) 
Advisor to Medtronic Inc
NOTES ON FORM 38.5(b)
1. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.
2. See the definition of "interest in a relevant security" in Rule 2.6 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules. If an option over new securities is acquired or exercised, the relevant interest should be disclosed under "(1) Relevant securities". If an option over existing relevant securities is acquired or exercised, the relevant interest should be disclosed under "(3) Options and
agreements to purchase/sell".
3. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.
4. For all prices and other monetary amounts, the currency must be stated.
5. If a long position has been increased or decreased as a result of the dealing, write "increased long" or "decreased long" respectively. If a short position has been increased or decreased as a
result of the dealing, write "increased short" or "decreased short" respectively. If the dealing has not resulted in a long or short position being increased or reduced, give details of the variation or other
dealing.
6. See Rule 2.6(d) of Part A of the Rules.
7. State type of dealing, e.g. "subscription", "conversion", "exercise" etc.
8. Where there are open option positions or open derivative positions (other than CFDs), or where there is an agreement to purchase or to sell, Supplemental Form 38.5(b) must be completed.
9. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2013.
FORM38.5(b)
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE38.5(b)OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DEALINGSBYCONNECTEDEXEMPTPRINCIPALTRADERSWITHOUTRECOGNISEDINTERMEDIARYSTATUS,ORWITHRECOGNISEDINTERMEDIARYSTATUSBUTNOTDEALINGINACLIENT-SERVINGCAPACITY
1.
KEY INFORMATION
Nameofexemptprincipaltrader
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
Companydealtin
Covidien PLC
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note1)
Common - IE00B68SQD29
Dateofdealing
25/08/2014
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

Long
Short
Number
%
Number
%
(1) 
Relevant securities 
63,556
0.014% 
186,066
0.041% 
(2) 
Derivatives (other than options) 
0
0% 
0
0% 
(3) 
Options and agreements to purchase/sell 
229,200
0.051% 
253,100
0.056% 
Total
292,756
0.065% 
439,166
0.097% 
(b)
Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 
Class of relevant security: 


Long
Short
Number
%
Number
%
(1) 
Relevant securities 




(2) 
Derivatives (other than options) 




(3) 
Options and agreements to purchase/sell 




Total




3.
DEALINGS (Note 3)
(a)
Purchases and Sales 
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
(USD) 
Purchase
2
87.52
Purchase
382
87.53
Purchase
155000
87.5967
Purchase
318
87.99
Purchase
100
88
Purchase
1754
88.01
Purchase
5229
88.02
Purchase
1258
88.03
Purchase
3665
88.04
Purchase
1463
88.05
Purchase
2457
88.06
Purchase
314
88.07
Purchase
2670
88.09
Purchase
313
88.12
Purchase
18
88.15
Purchase
316
88.17
Purchase
192
88.18
Purchase
118
88.26
Sale
1769
87.48
Sale
5021
87.49
Sale
6745
87.5
Sale
3677
87.51
Sale
3512
87.52
Sale
18329
87.53
Sale
7508
87.54
Sale
14368
87.55
Sale
29416
87.56
Sale
14400
87.57
Sale
3048
87.58
Sale
3038
87.59
Sale
55000
87.5967
Sale
7274
87.6
Sale
800
87.61
Sale
628
87.62
Sale
8
88.01
Sale
910
88.02
Sale
118
88.26
(b)
Derivatives transactions (other than options transactions) 
Product name,
e.g. CFD 
Nature of transaction
(Note 5)
Number of relevant securities
(Note 6)
Price per unit
(Note 4)
N/A
N/A
N/A
N/A
(c)
Options transactions in respect of existing relevant securities 
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call option 
Number of securities
Exercise price per
unit (Note 4)
N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)
Details
Price per unit
(if applicable) (Note 4)
N/A
N/A
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person 
disclosing and any other person relating to the voting rights of any relevant 
securities under any option referred to on this form or relating to the voting rights 
or future acquisition or disposal of any relevant securities to which any derivative 
referred to on this form is referenced. If none, this should be stated. 
1 shares returned
24 shares returned
Is a Supplemental Form 38.5(b) attached? (Note 8)
No
Date of disclosure:
26/08/2014
Contact name:
Stacy Otieno
Telephone number:
0207 995 1335
Name of offeree/offerer with which connected 
Medtronic Inc
Nature of connection (Note 9) 
Advisor to - Medtronic Inc
NOTES ON FORM 38.5(b)
1. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.
2. See the definition of "interest in a relevant security" in Rule 2.6 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules. If an option over new securities is acquired or exercised, the relevant interest should be disclosed under "(1) Relevant securities". If an option over existing relevant securities is acquired or exercised, the relevant interest should be disclosed under "(3) Options and
agreements to purchase/sell".
3. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.
4. For all prices and other monetary amounts, the currency must be stated.
5. If a long position has been increased or decreased as a result of the dealing, write "increased long" or "decreased long" respectively. If a short position has been increased or decreased as a
result of the dealing, write "increased short" or "decreased short" respectively. If the dealing has not resulted in a long or short position being increased or reduced, give details of the variation or other
dealing.
6. See Rule 2.6(d) of Part A of the Rules.
7. State type of dealing, e.g. "subscription", "conversion", "exercise" etc.
8. Where there are open option positions or open derivative positions (other than CFDs), or where there is an agreement to purchase or to sell, Supplemental Form 38.5(b) must be completed.
9. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2013.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISEBBGDISGDBGSL